Symbol="ACLX"
AssetType="Common Stock"
Name="Arcellx Inc"
Description="Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland."
CIK="1786205"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1722994000"
EBITDA="-192268992"
PERatio="None"
PEGRatio="None"
BookValue="6.08"
DividendPerShare="0"
DividendYield="0"
EPS="-4.31"
RevenuePerShareTTM="0.705"
ProfitMargin="0"
OperatingMarginTTM="-6.02"
ReturnOnAssetsTTM="-0.243"
ReturnOnEquityTTM="-0.593"
RevenueTTM="32213000"
GrossProfitTTM="0"
DilutedEPSTTM="-4.31"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="50.7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.12"
EVToRevenue="-"
EVToEBITDA="-7.34"
Beta="None"
num_52WeekHigh="48.91"
num_52WeekLow="16.73"
num_50DayMovingAverage="33.86"
num_200DayMovingAverage="32.7"
SharesOutstanding="48359000"
DividendDate="None"
ExDividendDate="None"
symbol="ACLX"
open="35.70"
high="36.21"
low="35.12"
price="35.52"
volume="355788.00"
latest_trading_day="2023-08-30"
previous_close="35.77"
change="-0.25"
change_percent="-0.6989%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="559070"
Change_recent_avg="0.06"
Delta_recent_avg="1.86"
Variance_recent_avg="0.93"
Change_ratio_recent_avg="0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="116"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_negative_thumbnail_id_2="141"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
